These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24215315)

  • 1. Use of thiazolidinediones and risk of bladder cancer: disease or drugs?
    Bazelier MT; de Vries F; Vestergaard P; Leufkens HG; De Bruin ML
    Curr Drug Saf; 2013 Nov; 8(5):364-70. PubMed ID: 24215315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
    Bazelier MT; Gallagher AM; van Staa TP; Cooper C; Leufkens HG; Vestergaard P; de Vries F
    Pharmacoepidemiol Drug Saf; 2012 May; 21(5):507-14. PubMed ID: 22392882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of fracture with thiazolidinediones: disease or drugs?
    Bazelier MT; Vestergaard P; Gallagher AM; van Staa TP; Cooper C; Leufkens HG; de Vries F
    Calcif Tissue Int; 2012 Jun; 90(6):450-7. PubMed ID: 22488176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study.
    Mamtani R; Haynes K; Bilker WB; Vaughn DJ; Strom BL; Glanz K; Lewis JD
    J Natl Cancer Inst; 2012 Sep; 104(18):1411-21. PubMed ID: 22878886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The thiazolidinediones rosiglitazone and pioglitazone and the risk of coronary heart disease: a retrospective cohort study using a US health insurance database.
    Ziyadeh N; McAfee AT; Koro C; Landon J; Arnold Chan K
    Clin Ther; 2009 Nov; 31(11):2665-77. PubMed ID: 20110009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study.
    Neumann A; Weill A; Ricordeau P; Fagot JP; Alla F; Allemand H
    Diabetologia; 2012 Jul; 55(7):1953-62. PubMed ID: 22460763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries.
    Korhonen P; Heintjes EM; Williams R; Hoti F; Christopher S; Majak M; Kool-Houweling L; Strongman H; Linder M; Dolin P; Bahmanyar S
    BMJ; 2016 Aug; 354():i3903. PubMed ID: 27530399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing pioglitazone to insulin with respect to cancer, cardiovascular and bone fracture endpoints, using propensity score weights.
    Vallarino C; Perez A; Fusco G; Liang H; Bron M; Manne S; Joseph G; Yu S
    Clin Drug Investig; 2013 Sep; 33(9):621-31. PubMed ID: 23881565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.
    Lewis JD; Habel LA; Quesenberry CP; Strom BL; Peng T; Hedderson MM; Ehrlich SF; Mamtani R; Bilker W; Vaughn DJ; Nessel L; Van Den Eeden SK; Ferrara A
    JAMA; 2015 Jul; 314(3):265-77. PubMed ID: 26197187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
    Lu CJ; Sun Y; Muo CH; Chen RC; Chen PC; Hsu CY
    Cerebrovasc Dis; 2013; 36(2):145-51. PubMed ID: 24029780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.
    Lewis JD; Ferrara A; Peng T; Hedderson M; Bilker WB; Quesenberry CP; Vaughn DJ; Nessel L; Selby J; Strom BL
    Diabetes Care; 2011 Apr; 34(4):916-22. PubMed ID: 21447663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
    Wang CC; Chen WL; Kao TW; Chang YW; Loh CH; Chou CC
    Clin Ther; 2011 Dec; 33(12):1904-13. PubMed ID: 22118894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone use and risk of bladder cancer: population based cohort study.
    Tuccori M; Filion KB; Yin H; Yu OH; Platt RW; Azoulay L
    BMJ; 2016 Mar; 352():i1541. PubMed ID: 27029385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?
    Tseng CH
    J Formos Med Assoc; 2012 Mar; 111(3):123-31. PubMed ID: 22423665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pioglitazone and bladder cancer: a propensity score matched cohort study.
    Wei L; MacDonald TM; Mackenzie IS
    Br J Clin Pharmacol; 2013 Jan; 75(1):254-9. PubMed ID: 22574756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of biguanides and the risk of colorectal cancer: a register-based cohort study.
    Knapen LM; Dittrich ST; de Vries F; Starup-Linde J; Vestergaard P; Henry RM; Stolk LM; Neef C; Bazelier MT
    Curr Drug Saf; 2013 Nov; 8(5):349-56. PubMed ID: 24215310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone use and the risk of bladder cancer.
    Kuo HW; Tiao MM; Ho SC; Yang CY
    Kaohsiung J Med Sci; 2014 Feb; 30(2):94-7. PubMed ID: 24444539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria testing among patients with diabetes mellitus is associated with bladder cancer diagnosis: potential for unmeasured confounding in studies of pioglitazone and bladder cancer.
    Lewis JD; Habel L; Quesenberry C; Mamtani R; Peng T; Bilker WB; Hedderson M; Nessel L; Vaughn DJ; Strom BL; Ferrara A
    Pharmacoepidemiol Drug Saf; 2014 Jun; 23(6):636-45. PubMed ID: 24764283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.
    Lin HC; Hsu YT; Kachingwe BH; Hsu CY; Uang YS; Wang LH
    J Clin Pharm Ther; 2014 Aug; 39(4):354-60. PubMed ID: 24661226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible link of pioglitazone with bladder cancer in Japanese patients with type 2 diabetes.
    Fujimoto K; Hamamoto Y; Honjo S; Kawasaki Y; Mori K; Tatsuoka H; Matsuoka A; Wada Y; Ikeda H; Fujikawa J; Koshiyama H
    Diabetes Res Clin Pract; 2013 Feb; 99(2):e21-3. PubMed ID: 23228390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.